A61K 9/5184
Virus capsids or envelopes enclosing drugs
Official title: {Virus capsids or envelopes enclosing drugs (liposomes with additional exogenous lipids A61K9/127)}
A61K9/5184 (Virus capsids or envelopes enclosing drugs) appears on 124 US grants and 330 published applications in this corpus.
Search patents in A61K- Granted patents
- 124
- Published applications
- 330
- Assignees
- 213
- Inventors
- 748
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 1 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 3 | 5 |
| 2007 | 0 | 4 |
| 2008 | 2 | 2 |
| 2009 | 2 | 6 |
| 2010 | 0 | 6 |
| 2011 | 4 | 8 |
| 2012 | 3 | 9 |
| 2013 | 2 | 8 |
| 2014 | 4 | 6 |
| 2015 | 6 | 5 |
| 2016 | 2 | 9 |
| 2017 | 8 | 11 |
| 2018 | 4 | 8 |
| 2019 | 8 | 19 |
| 2020 | 6 | 18 |
| 2021 | 4 | 31 |
| 2022 | 6 | 36 |
| 2023 | 8 | 25 |
| 2024 | 8 | 42 |
| 2025 | 15 | 42 |
| 2026 | 11 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cell-receptor targeted exosomes6 Oct 2026US 12,751,930 B2City of Hope
- Apparatus, methods, and systems for providing pharmaceutical compositions in the form of droplets for aerosol administration and inhalation delivery25 Aug 2026US 12,714,705 B2
- Anellosomes and methods of use26 May 2026US 12,637,693 B2Flagship Pioneering Innovations V, Inc.
- Plant-derived exosome-like nanoparticles inhibit bacterial pathogenicity5 May 2026US 12,616,663 B2University of Louisville Research Foundation, Inc.
- Arc-based capsids and uses thereof5 May 2026US 12,617,822 B2Aera Therapeutics, Inc.
- Primate carbonic anhydrase iv binding peptides and aavs1 Oct 2026US 2026/0294834 A1California lnstitute of Technology
- Extracellular vesicle, preparation method, pharmaceutical composition and application thereof17 Sep 2026US 2026/0272834 A1Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences
- Hepatitis e virus-like particles (vlps) derived from consensus sequences10 Sep 2026US 2026/0263379 A1Novo Capsid Technologies LLC
- Pharmaceutical formulations of gene delivery vehicles13 Aug 2026US 2026/0234617 A1uniQure biopharma B.V.
- Compositions and methods for enhanced drug loading into lipid-based carriers30 Jul 2026US 2026/0216093 A1University of Notre Dame du Lac
Most cited
By later US patents
- Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)108US 6,309,634 B1Avigen, Inc. · 2001
- Methods of treating central nervous system disorders using viral vectors46US 6,953,575 B2Avigen, Inc. · 2005
- Polypeptides and vectors for targeting HER2/neu expressing cells and uses thereof40US 9,598,468 B2University of Florida Research Foundation, Inc. · 2017
- Methods of treating Parkinson's disease using viral vectors33US 8,309,355 B2Genzyme Corporation · 2012
- RNA bacteriophage-based delivery system32US 6,159,728 ABTG International Limited · 2000